Regional Manager Diabetes & Metabolic Health (West and East Flanders)

Belgium

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's or Master's degree with a focus on health or healthcare, coupled with experience in pharmaceutical sales or a customer-facing commercial role. Essential qualities include self-drive, self-motivation, passion, enthusiasm, persuasion, strong listening, communication, and interpersonal skills, along with the ability to engage in high-level customer exchanges and master Value Based Selling techniques.

Responsibilities

The Regional Manager will oversee the commercial aspects of the diabetes and metabolic health portfolio within West and East Flanders, driving sales and promotion to specialists like Diabetologists and Endocrinologists. Responsibilities include executing customer-facing activities, delivering exceptional customer experiences, managing key products and launches, acting as a product ambassador, developing account plans, excelling in territory management, implementing multichannel strategies, collaborating cross-functionally with internal teams and Medical Affairs, and ensuring compliance with adverse event reporting and sample management.

Skills

Sales

Promotion

Customer Relationship Management

Territory Management

Account Planning

Value Based Selling

Diabetes

Metabolic Health

Product Knowledge

Market Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free